Brief: Fusion Antibodies Says On Track For Commercial Launch Of Optimal In December 2025
03/11/2025 07:29
Nov 3 (Reuters) - Fusion Antibodies PLC FAB.L: ON TRACK FOR COMMERCIAL LAUNCH OF OPTIMAL IN DECEMBER 2025 ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Fusion Antibodies
See all newsBrief: Fusion Antibodies Announces New TGE And Cryoem Project With US Pharma Client
Fusion Antibodies - Contract win
Fusion Antibodies - AGM statement H1 trading and research update
RCS - Fusion Antibodies - Launch of new customer-focused website
Fusion Antibodies - Posting of Annual Report & Notice of AGM